Researchers from LUMC, Amsterdam UMC, the University of Copenhagen and the Oncode Institute have developed a new method to detect microscopic particles shed by cancer cells. This study stands out for two key reasons: the identification of a sugar coating that is uniquely expressed on tumor vesicles, and the incorporation of direct input from cancer patients. These tumor vesicles may serve as early indicators of cancer and help monitor the effectiveness of treatments.
Read more&width=710&height=710)
Introduction
LUMC strongly underpins the idea that ‘Science is the driving force behind innovative healthcare’. Outcomes of top level fundamental, translational and clinical research by LUMC researchers form a strong basis for innovative and qualitative healthcare on a national, European and international level.
A real game changer was the development of the Dutch national research agenda (NWA) in 2015. The agenda reveals the complexity of the issues challenging Dutch society today. These issues are clustered in so called routes. LUMC is involved in many of these routes and contributes this way to solving important societal challenges.